CD274 and neoplasm: These inhibitory effects on tumor growth were accompanied by a decrease in the expression of PD-L1 in CD45− cells in the tumors, consistent with the anticipated mechanism of action of this compound, which promotes loss of cell surface PD-L1 (Fig. 3B).